The bacterial lacZ gene encoding for b-galactosidase (b-gal) is a common reporter gene used in transgenic mice. Nonetheless, the absence of fluorigenic substrates usable in live animals greatly hampered the non-invasive follow-up of this reporter gene expression. We used far-red fluorescence for imaging b-Gal expression in live cells in vitro or in vivo. The 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) b-D-galactopyranoside substrate was used to monitor b-Gal expression as a reporter of tumor growth, or of the physiological levels of an endogenous gene or of gene transfer in lung. A quantitative evaluation of this method as well as a comparison of its sensitivity with Firefly Luciferase-based bioluminescence was also performed.
Introduction
Reporter genes, such as b-Galactosidase (b-Gal), Chloramphenicol Acetyltransferase, Luciferase and Green Fluorescent Protein, are widely used in biological systems. 1 Since most of these reporters are detected in vitro on tissue sections, biopsies or postmortem samples, these methods are not suitable for a long-term follow-up of gene expression and regulation. 2 Several studies recently established that reporters such as Luciferases, 3 Thymidine Kinases 4, 5 and Green Fluorescent Protein 6 could be detected non-invasively. Adapted imaging modalities were developed, with variable resolutions, sensitivities and cost. In addition, most of these methods are semi-quantitative or qualitative only. 7 The bacterial lacZ gene, which encodes the b-Gal enzyme, is the most commonly used reporter gene, because of its historical availability and the existence of a large panel of chromogenic 8, 9 and fluorogenic [10] [11] [12] [13] substrates. Nonetheless, the use of these products required the killing of the animals, until the description of a noninvasive visualization of b-Gal expression using a gadolinium-based probe and magnetic resonance imaging.
14 Latter on, a radioiodinated competitive inhibitor of the b-Gal enzyme as well as a b-Gal substrate with far-red fluorogenic properties were successfully used for in vivo imaging. 15, 16 Meanwhile, innovative advances in optical imaging technologies and especially the development of highly sensitive photon-detection cameras, allowed cell biologists to carry out quantitative examination of whole-cell structure and function with high spatial and temporal resolution. The rapid adaptation of these tools as well as the development of dedicated equipments for imaging deep tissues in live animals is currently influencing how researchers can approach molecular processes in vivo. 17 Light in the visible-wavelength spectrum is routinely used for conventional and intravital microscopy. 18 Although extremely powerful, methods like confocal and multiphoton microscopy allow imaging of superficial locations down to a few hundred micrometers only, due to optical constraints inherent to the physics of these instruments. In addition, most of the fluorophores currently in use are working in the 450-600 nm spectral region. This will also limit the path of light through the sample because biological tissues are strongly absorbing in the visible range. Deeper events, typically ranging from 1 to 10 millimeters under the skin surface, can be visualized using macroscopic epi-illumination imaging (called 2D-fluorescence reflectance imaging (FRI)). This also require the use of far-red (600-650 nm) or near-infrared (650-900 nm) fluorophores to reduce tissue absorption and to avoid most of the problems of autofluorescence coming mainly from the constituents of the extracellular matrix (collagens, elastin and many more) especially in the skin.
In this study, we used 2D-FRI far-red fluorescence for direct and non-invasive imaging of the b-gal reporter gene expression in live mice. For this purpose, the 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) b-Dgalactopyranoside (DDAOG) 19 was administered by an intracardiac injection, to visualize the pattern of expression of b-Gal in the lung of mice after polyethylenimine (PEI)-mediated non-viral delivery of a pCMV-lacZ plasmid, or in a transgenic strain of mice expressing physiological levels of b-Gal. A comparison of the sensitivity and limitations of this method as compared to bioluminescence detection of Luciferase in vivo is also presented.
Results

Quantitative imaging of b-Gal activity in vitro
A b-Gal stable clone derived from the murine breast carcinoma Ts/Apc cells was established. Using a standardized chemiluminescent in vitro b-Gal assay, we measured 250 nU cell À1 of b-Gal enzymatic activity, corresponding to 63 mU of b-Gal produced per mg of protein.
Imaging of increasing quantities of these cells seeded in 24 wells with the fluorogenic DDAOG b-Gal substrate gives a linear relation between the detected fluorescence (relative light units per pixel (RLU per pixel)) and the number of cells ( Figure 1) . As a rule, we set up the cut-off at 4500 RLU per pixel, which represents 1.5-fold the background level. Accordingly, as little as 2.10 4 cells per well can be detected, and this measure was linear until at least 2 Â 10 5 cells per well.
Quantitative imaging of b-Gal activity produced by tumor cells in vivo in mice
Mice bearing subcutaneous matrigel plugs containing increasing numbers of b-Gal Ts/Apc cells were imaged before and immediately after intracardiac injection of DDAOG.
As indicated in Figure 2a , the background level of fluorescence measured beside the mouse (noise) remained constant at 1884 RLU per pixel during the experiment. Before DDAOG injection (T ¼ 0), the fluorescence level was 4761 RLU per pixel in the normal skin and 5542 RLU per pixel in the plug, representing a measure of the autofluorescence. Fifteen minutes after DDAOG injection, the signal in the skin rose to 7230 RLU per pixel and stabilized later on at a baseline level around 6400 RLU per pixel. This level in the skin represented the sum of the noise, plus autofluorescence, plus nonspecific signal coming from a possible degradation of DDAOG in normal tissues. In the plug, fluorescence increased during the first 60 min after substrate injection, reached a plateau around 13 000 RLU per pixel between 60 and 120 min and then slowly decreased ( Figure 2a ). As shown in Figure 2b , the plug imaged in these conditions was very clearly visualized on the whole animal.
Inoculation of increasing quantities of b-Gal Ts/Apc cells in the plugs allowed us to demonstrate that as little as 10 3 b-Gal cells can be specifically detected. As a standard, we decided that the signal had to be more elevated than 1.5 times the normal skin value before being considered as positive. Plugs containing 100 cells were not discernible from the normal skin (61407100 vs 5609794 RLU per pixel). Positivity was reached when as little as 103 cells were included in the plug, with a plug/ skin ratio of 1.5, which increased to 4.6 when 106 cells were engrafted in the plug (Figure 2c ).
In vivo imaging of gene transfer in mice
Mice lung were transfected by an intravenous injection of PEI-DNA complexes as described previously. 20 Fifty micrograms of pCMV-lacZ or pCMV-luc plasmids was mixed with PEI and injected intravenously. Twenty-four hours later, the level of expression of each reporter gene was measured using either DDAOG and fluorescence or luciferin and bioluminescence in anesthetized mice.
As expected, both methods revealed the presence of the reporter enzymes in the lung (Figure 3) . In b-Galtransfected mice, fluorescence was observed in the lung 60 min after DDAOG injection in live animals or after killing and/or extraction of the lung. No false b-Galpositive signal was detected in the lung of pCMV-luctransfected (Figures 3a and b) or of not transfected control animals (data not shown). The stomach was strongly positive, both before and after the injection due to the autofluorescence of the food. The presence of b-Gal in the lung of pCMV-lacZ-transfected animals was then confirmed by the presence of the expected blue color in the alveoli of X-gal-stained lung (Figure 3b ).
The intensities of fluorescence or bioluminescence emissions were measured in vivo from the lung of several animals expressing different levels of each reporter gene after PEI-mediated transfection (n ¼ 8 and 7 per group, respectively). The animals were then killed, the lung extracted, chopped and the b-Gal or Luc activities measured on the protein extracts using standard, quantitative methods in vitro (Figure 3c ). In both cases, very good linear relations were observed between the in vitro assays and the in vivo detection (R 2 ¼ 0.98 for both). The sensibility was also found to be very similar, since as little as 5 ng of enzyme per mg of proteins were detectable non-invasively in the lung.
In vivo imaging of physiological levels of lacZ gene expression in mice
To demonstrate the interest of DDAOG-based fluorescence to follow the expression of a physiological level of Reporter gene fluorescence imaging V Josserand et al the b-Gal reporter enzyme, we used a transgenic mouse in which lacZ is under control of the human VE-cadherin promoter.
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These b-Gal transgenic mice (n ¼ 14) received an intracardiac injection of DDAOG and were imaged 60 min later. As shown in Figure 4 , the whole body of the transgenic mice were much fluorescent than the control mice (Figures 4a and b) . After killing, removal of the skin and stomach and exposure of the organs, the fluorescence was found in the lung, testis, kidney and gut ( Figure 4c ).
The dissected organs were imaged separately (Figure 4d ), and the fluorescence measured from the isolated organs with the CCD camera was correlated to the b-Gal expression quantified in vitro (Figure 4e ). When these results were plotted on a graph, a strong correlation was observed between the sensibility of the CCD measurements and the color of the organs as soon as the organs were grouped into three categories. A first group composed of 'clear' organs such as brain, lung, intestine, muscle, thymus, testis, ovaries and salivary glands; (2) a group of 'red' organs such as heart, liver and kidney; and (3) a 'dark red' group for the spleen only (Figure 4e ). Because of their clear color and low index of absorption, organs from the first group allowed a better retrodiffusion of the emitted photons as compared to those of groups 2 or 3, and thus a better sensitivity of CCD detection. As an example, for a measured enzymatic activity of 20 mU mg À1 of protein, the CCD values decreased from more than 10 000 RLU per pixel for the organs of group 1 to less than 6000 for those of group 2 and down to 3000 in the spleen. Thus, an accurate ex vivo measurement of b-Gal activity using fluorescent methods in whole organs has to be corrected by a function of its absorbance, but our results suggested that a simple correction should be used. These corrections are based on the equations of the curves presented in Figure 4e for each group of organs. Since these corrections depends on the type of CCD chips in the camera and photomultiplicator included in the plate reader used for measuring Reporter gene fluorescence imaging V Josserand et al b-Gal activity, these corrections will have to be calibrated first for each system.
Discussion
The previously published b-Gal substrate DDAOG 19 was shown to have far-red fluorogenic properties very convenient for in vivo imaging. 16 Indeed, this compound displays a 50 nm red shift when cleaved by the b-Gal, enabling its specific detection while the intact probe is not emitting any background, a highly desirable feature for in vivo imaging.
In the present study, this smart fluorogenic substrate was used to monitor (1) b-Gal expression as a reporter of genetically modified tumor growth, (2) stable physiological levels of an endogenous gene expression and (3) PEImediated, non-viral gene transfer in lung. In addition, quantitative evaluation of this method as well as a comparison of its sensitivity with firefly Luciferase-based bioluminescence was addressed.
Genetically modified tumor cells, stably transfected with a pCMV-lacZ plasmid encoding for b-Gal can be detected in vitro and in vivo using DDAOG. In vitro measurements showed that the intensity of the signal was a linear function of the number of cells. Each cell produced an average of 2.3170.07 photon pixel À1 s À1 . The pattern was somehow different in vivo: the fluorescence intensity varied as a function of the log of the number of cells. This suggested that light absorption in the thickness of the plug affected the quantification. Using 3D tomography should normally solve this problem.
Nonetheless, as little as 10 3 b-Gal-positive tumor cells, engrafted subcutaneously in the matrigel plugs were detected in vivo. This good sensitivity was close from the one described using bioluminescence for imaging Luciferase-positive tumors. 3, 22 The sensitivity was largely due to the low background of surrounding tissues, pointing out the advantage of using an activatable substrate. Indeed, DDAOG is not emitting in our working spectrum unless it is metabolized by the b-Gal enzyme, and thus it generates minimum circulating background. Nonetheless, a small part of the substrate was nonspecifically metabolized and caused limited nonspecific fluorescence signal.
We then compared the sensitivity of both optical methods for imaging gene transfer in vivo. This was performed after PEI-mediated gene delivery to the lung, using the luc and b-gal reporter genes. Immediately after imaging the animals were killed, the lung was exposed to the camera for 500 ms (panel b, top). As shown, the lungs of pCMV-lacZ-transfected animals were strongly fluorescent due to the DDAOG treatment (b, top left), whereas the pCMV-luc-transfected animals remained negative (b, top right). Part of these tissues were then fixed and stained in toto using X-gal, showing in blue the presence of lacZ expressing cells in the alveoli of pCMV-lacZ-transfected (b, bottom left) but not of pCMV-luc-transfected animals (b, bottom right). (c) All the pCMV-lacZ-and pCMV-luc-transfected animals were imaged as described in (a) and the average intensity of light coming from the fluorescent or bioluminescent lungs were recorded. These animals were then killed, and the presence of b-Gal or of Luciferase was measured using standard in vitro assays. As presented in both graphs, a very good correlation was obtained between the in vivo and in vitro measurements for each reporter gene. DDAOG, 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) b-D-galactopyranoside; PEI, polyethylenimine.
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As expected, 23-25 expression of these two reporter genes was strongly restricted to the lung. Concentrations of 5 ng of enzyme per mg of lung proteins were easily detectable when using Luciferase and bioluminescence as well as b-Gal and 2D-FRI. In agreement with the previous in vitro or in vivo measurements, this confirmed that both techniques provided a similar sensibility. Nonetheless, exposure times were strongly reduced in 2D-FRI as compared to BLI. Indeed, typical exposures of 100 ms instead of 2-10 min were used. Thus, since it reduced significantly the duration of each acquisition, FRI would be more adapted to High-Throughput Screening methods requiring a large number of animals.
Imaging the b-Gal transgenic mouse expressing lacZ under control of a VE-cadherin promoter was also successful. Non-invasive whole-body imaging of the mice showed a much brighter fluorescence than the lacZnegative controls. Imaging of the exposed organs after killing confirmed the presence of b-Gal in the lung, testis, kidney and guts, as described previously. 21 A quantitative comparison of b-Gal levels measured with NIR imaging or using a standardized enzymatic evaluation in vivo revealed how strongly optical properties of the organs were affecting the linearity of the CCD detection. When 'clear' organs were used, a good correlation was observed between the fluorescence measurement and the in vitro b-Gal assay. On the other hand, lacZ expression in colored organs was always underestimated by the NIR measurements. The worst situation was observed with the spleen, for which no satisfying correlation could be established.
These results demonstrated the feasibility of the in vivo imaging of the regulation of an endogenous gene using lacZ and NIR imaging. However they also draw attention to weak points of 2D-FRI, which cannot supply absolute quantitative measurements and is submitted to a colordependent disparity of the organs. This problem is mainly related to light absorption by organic tissues. Indeed, molecules like hemoglobin or oxyhemoglobin are absorbing very strongly the photons with wavelengths ranging between 450 and 650 nm (visible light). Using infrared light is not satisfying either, since water is absorbing in the 900-2500 nm spectrum. The 650-900 nm window remains the more adapted for imaging deep organs. Thus, one way to improve b-gal imaging would be to use a more red-shifted molecule than DDAOG.
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2D-FRI is currently a method of choice because it is easy to use, it allows rapid data acquisition for screening of a large number of animals and because the data are simple to analyze. It is also a sensitive method and imaging of subpicomole amounts of fluorochromes has been described. Finally, although FRI systems are not intrinsically quantitative, they can provide semi-quantitative data when the fluorescence signal lay near the surface.
Three-dimensional tomographic molecular imaging (fluorescence molecular tomography) should improve the detection of NIR signals coming from deep organs. In addition, this method is described to increase the linearity of the measurements of enzymatic activities. Hence, it should improve significantly the performance of the NIR detection of b-Gal in vivo. Nonetheless, fluorescence molecular tomography still requires advanced reconstruction methods 26 and more sophisticated apparatus.
In conclusion, 2D-FRI is a very powerful, non-invasive method allowing rapid and sensitive longitudinal follow-up of gene expression in live small rodents. Despite some drawbacks in terms of linearity, the design of red-shifted substrates and the widespread use of 3D-fluorescence molecular tomography will certainly make of optical imaging a method of choice for following the lacZ reporter gene expression in live animals.
Materials and methods
b-Gal stable transfection
Twenty-four hours before transfection, 10 6 Ts/Apc cells (murine breast carcinoma) were seeded in Petri dishes with RPMI 1640 medium supplemented with 10% fetal calf serum, penicillin (50 U ml À1 ), streptomycin (50 mg ml
À1
) and b-mercaptoethanol (2.5.10 À5 M) and incubated at 37 1C in a 5% CO 2 atmosphere. Stable transfections of Ts/Apc cells were performed using Jet-PEI (Polyplus Transfection, Illkirch, France) and a 4:1 ratio of pCMV-lacZ and pCDNA3 plasmids, followed by G418 (Invitrogen, Cergy Pontoise, France) selection and cloning of positive cells.
Fluorescence imaging set up
All animal experiments were conducted in agreement with the 'Principles of Laboratory Animal Care' (NIH publication no. 86-23, revised 1985) . 
b-Gal Ts/Apc matrigel plugs in mice
Two hours before imaging, various numbers of b-Gal Ts/Apc cells (from 0 to 10 6 cells) in 250 ml Matrigel (BD Biosciences, Erembodegem, Belgium) were implanted subcutaneously on female Swiss nude mice (6-8 weeks old; Janvier, le Genest Saint Isle, France). Fluorescence imaging was then performed with a 500 ms exposure time before the substrate injection and 15, 30, 45, 60, 90, 120 and 180 min after injection. The signal in the plug, in the skin or beside the mice was measured on a region of interest and was expressed in RLU per pixel. The plug/ skin ratio was calculated as follows:
(signal in the plug at t ¼ 60 minÀthe signal in the plug before DDAOG injection)/(signal in the skin at t ¼ 60 minÀthe signal in the skin before DDAOG injection).
In vivo gene transfer in mice pCMV-lacZ and pCMV-luc plasmids (Promega, Charbonnières, France) were used as reporter genes for the gene transfer using in vivo Jet-PEI (Polyplus Transfection). Briefly, 50 mg of endotoxin-free plasmids was mixed with a ratio of L-PEI nitrogen to DNA phosphate of 10 in 200 ml of 5% w/v glucose. After 15 min incubation at room temperature, the L-PEI/DNA mixture was injected in the tail vein of female Swiss nude mice (6 weeks old; Janvier).
b-Gal or Luc activities imaging were performed 24 h later. Luciferin (Promega) was injected intraperitoneally (300 ml, 150 mg kg
À1
) and the mice were imaged 5 min later with a 2 min exposure time and a 2 Â 2 binning. DDAOG was injected very rapidly into the left ventricle (0.5 mg, 100 ml) and images were taken with a 500 ms exposure time, before and 60 min after injection and finally after killing and removal of the skin.
Lungs from lacZ and luc genes-transfected mice were removed and their b-Gal or Luc activities were assayed ex vivo using the CCD camera and the conventional enzymatic methods.
b-Gal transgenic mice
VEcad-lacZ transgenic mice 21 and CD1 control mice (Charles River, l'Arbresle, France) were anesthetized and shaved with small animal clippers. b-Gal activity imaging was performed with 100-500 ms exposure times, before the substrate injection and every 10 s from the injection to 18 min after injection and then at 30 and 60 min after injection. At 60 min the mice were dissected, the separated organs were imaged and their b-Gal activity was assayed in vitro using a conventional enzymatic method.
Measuring b-Gal and Luc enzymatic activities in vitro with standard assays b-Gal and Luc activities were assayed in vitro using the b-Gal Assay System or the Luciferase Assay System (Promega) as recommended by the manufacturer.
Briefly, tissues were extracted and cut into small pieces with a razor blade. Fragments were mixed thoroughly in 1 ml of lysis buffer. After 15 min incubation, the samples were frozen at À20 1C. The following day, the samples were thawed and brought to room temperature before centrifugation (2 min, 15 600 g). The supernatants were then used for b-Gal or Luc activity assays and proteins content assay. The proteins content was measured using the DC-comp Bio-Rad assay (Bio-Rad, Marnes-laCoquette, France).
In vitro b-Gal activity assay. Fifty microliters of the extract were added to 50 ml of assay 2 Â buffer and incubated 30 min at 37 1C. The reaction was stopped by adding 150 ml of sodium carbonate 1 M and the absorbance was read at 420 nm on a spectrophotometer (BioRad). The b-Gal activities were expressed as a number of mU per mg of protein (1 mU corresponding to the hydrolysis of 1 nmol of substrate per minute at pH 7.5 and 37 1C). As a reference, using purified b-Gal under the same experimental conditions, we determined that 2 ng of this enzyme produced 0.654 mU.
In vitro Luciferase activity assay. Ten microliters of extracts was mixed with 100 ml of Luciferase assay substrate and the Luciferase activities were measured for 10 s on a photoluminometer (Berthold, Illkirch, France). The Luciferase activities were calculated as number of Reference Light Unit per 10 s per mg of protein (RLU per 10 s mg À1 ). As a reference, using purified firefly Luciferase under the same experimental 
